检索

期
标题
作者
卷 26, 编号 12 (2019)
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E., Frolova M., Menshikov S., Stenina M.
PDF
(Rus)
编号 17 (2013)
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.
PDF
(Rus)
卷 28, 编号 7 (2021)
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K., Vorontsova K., Kuko T., Prosvirnov A., Ganshina I., Lubennikova E., Kolyadina I., Zhukova L.
PDF
(Rus)
卷 29, 编号 11/12 (2022)
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V., Krivorotko P., Komyakhov A., Semiglazova T., Gigolaeva L., Tabagua T., Kazantseva M., Tergoeva A., Ulrikh D., Chervyak M., Klimenko V., Amirov N., Zhiltsova E., Semiglazov V.
PDF
(Rus)
编号 8 (2015)
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S., Laytsan K., Stroyakovskiy D., Demidova I., Gorbunova V.
PDF
(Rus)
编号 8 (2015)
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S., Stepanchenko M., Lichinitser M.
PDF
(Rus)
卷 28, 编号 11 (2021)
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M., Kuzina L.
PDF
(Rus)
编号 8 (2015)
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Paltuev R.
PDF
(Rus)
卷 28, 编号 7 (2021)
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E., Zhukova L., Gordeeva O., Drobot N., Kuznetsov A., Ganshina I.
PDF
(Rus)
卷 26, 编号 7 (2019)
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
Sakaeva D., Nasretdinov A.
PDF
(Rus)
编号 7 (2018)
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D., Iskhakova A., Kunafina R.
PDF
(Rus)
编号 17 (2017)
Palbociclib - new possibilities of therapy of hormon-positive HER2-negative breast cancer
Zhukova L., Chichikov E., Gordeeva O., Filonenko D.
PDF
(Rus)
卷 26, 编号 7 (2019)
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
Vladimirova L., Popova I., Abramova N., Storozhakova A., Tikhanovskaya N., Novoselova K., Lyanova A., Ryadinskaya L., Yezhova M., Teplyakov M.
PDF
(Rus)
编号 8 (2013)
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.
PDF
(Rus)
编号 18 (2012)
Chemotherapy of anthracy-clineand taxan-resistant breast cancer
Kovalenko E., Satirova E., Artamonova E., Manzyuk L.
PDF
(Rus)
编号 17 (2016)
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
Artamonova E., Bolotina L., Gligorov Z., Zhukov N., Zhukova L., Imyanitov E., Karabina E., Kovalenko E., Lichinitser M., Manzyuk L., Semiglazov V., Semiglazova T., Stroyakovsky D.
PDF
(Rus)
1 - 16 的 16 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##